0001209191-20-062955.txt : 20201211
0001209191-20-062955.hdr.sgml : 20201211
20201211164249
ACCESSION NUMBER: 0001209191-20-062955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatfield Jeffrey S.
CENTRAL INDEX KEY: 0001609879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 201383971
MAIL ADDRESS:
STREET 1: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-09
0
0001706431
Vir Biotechnology, Inc.
VIR
0001609879
Hatfield Jeffrey S.
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO
CA
94158
1
0
0
0
Stock Option (Right to Buy)
29.43
2020-12-09
4
A
0
46500
0.00
A
2030-12-08
Common Stock
46500
46500
D
1/3 of the shares subject to the stock option vest and become exercisable on December 9, 2021, and the remaining shares vest in 24 equal monthly installments thereafter.
/s/ Howard Horn, Attorney-in-Fact
2020-12-11